| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,791 |
4,233 |
$566K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,067 |
1,909 |
$364K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
877 |
839 |
$213K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,500 |
1,328 |
$120K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,416 |
1,332 |
$115K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
399 |
391 |
$51K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
918 |
916 |
$47K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
549 |
511 |
$40K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,374 |
1,147 |
$36K |
| 70450 |
Computed tomography, head or brain; without contrast material |
429 |
421 |
$36K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,381 |
1,152 |
$30K |
| 71046 |
Radiologic examination, chest; 2 views |
1,002 |
966 |
$28K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
30 |
24 |
$24K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
528 |
175 |
$21K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
581 |
567 |
$18K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
230 |
226 |
$15K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
594 |
153 |
$13K |
| 71045 |
Radiologic examination, chest; single view |
403 |
394 |
$11K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
839 |
838 |
$11K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
85 |
84 |
$8K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
16 |
15 |
$5K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
26 |
26 |
$5K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
13 |
13 |
$5K |
| 95811 |
|
12 |
12 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
503 |
495 |
$3K |
| 80053 |
Comprehensive metabolic panel |
2,697 |
2,445 |
$3K |
| 76830 |
Ultrasound, transvaginal |
53 |
53 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,204 |
2,790 |
$3K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
39 |
37 |
$3K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,242 |
1,137 |
$2K |
| 76642 |
|
79 |
77 |
$2K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
312 |
307 |
$2K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
169 |
167 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
1,822 |
1,617 |
$2K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
32 |
32 |
$2K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
28 |
28 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,237 |
1,013 |
$1K |
| 80061 |
Lipid panel |
153 |
149 |
$1K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
533 |
490 |
$926.03 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
35 |
12 |
$808.60 |
| 84439 |
|
252 |
250 |
$788.11 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
185 |
177 |
$765.39 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
12 |
12 |
$753.85 |
| 83735 |
|
1,002 |
919 |
$399.00 |
| 72100 |
|
27 |
25 |
$391.07 |
| 85610 |
|
868 |
790 |
$353.14 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
468 |
461 |
$345.44 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
14 |
14 |
$250.17 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
143 |
133 |
$202.87 |
| 73630 |
|
56 |
52 |
$185.10 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
320 |
314 |
$109.42 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
339 |
337 |
$103.76 |
| 85379 |
|
263 |
252 |
$78.04 |
| 83690 |
|
905 |
830 |
$74.32 |
| 82150 |
|
477 |
452 |
$57.13 |
| 73562 |
|
17 |
15 |
$52.35 |
| 81003 |
|
1,584 |
1,492 |
$49.57 |
| 85730 |
|
666 |
647 |
$44.25 |
| 81025 |
|
969 |
901 |
$43.21 |
| 85027 |
|
12 |
12 |
$39.92 |
| 81001 |
|
209 |
199 |
$37.80 |
| 73610 |
|
26 |
26 |
$31.59 |
| 83880 |
|
14 |
14 |
$21.33 |
| 84484 |
|
868 |
800 |
$15.84 |
| 96376 |
|
202 |
160 |
$0.00 |
| 87040 |
|
41 |
40 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
402 |
357 |
$0.00 |
| 84703 |
|
53 |
53 |
$0.00 |
| 87807 |
|
27 |
27 |
$0.00 |
| A9270 |
Non-covered item or service |
61 |
40 |
$0.00 |
| 94760 |
|
74 |
73 |
$0.00 |
| V2632 |
Posterior chamber intraocular lens |
32 |
26 |
$0.00 |
| 83605 |
|
19 |
19 |
$0.00 |
| 94664 |
|
339 |
312 |
$0.00 |
| L8613 |
Ossicula implant |
12 |
12 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
26 |
25 |
$0.00 |